Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Binding mechanism and biological effects of flavone DYRK1A inhibitors for the design of new antidiabetics ; volume:13 ; number:1 ; day:23 ; month:10 ; year:2023 ; pages:1-18 ; date:12.2023
Scientific reports ; 13, Heft 1 (23.10.2023), 1-18, 12.2023
- Creator
-
Pustelny, Katarzyna
Grygier, Przemyslaw
Barzowska, Agata
Pucelik, Barbara
Matsuda, Alex
Mrowiec, Krzysztof
Slugocka, Emilia
Popowicz, Grzegorz M.
Dubin, Grzegorz
Czarna, Anna
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44810-3
- URN
-
urn:nbn:de:101:1-2024020908033004231436
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Pustelny, Katarzyna
- Grygier, Przemyslaw
- Barzowska, Agata
- Pucelik, Barbara
- Matsuda, Alex
- Mrowiec, Krzysztof
- Slugocka, Emilia
- Popowicz, Grzegorz M.
- Dubin, Grzegorz
- Czarna, Anna
- SpringerLink (Online service)
Other Objects (12)
Structural mechanism of SGLT1 inhibitors
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K‐Ras4b Inhibitors
Unmasking the biological function and regulatory mechanism of NOC2L: a novel inhibitor of histone acetyltransferase
Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation
Biological functions of proteases and inhibitors
Characterization of the bipartite binding mechanism of Yos9
Mechanism of Action of Halofenate, A Platelet Inhibitor
Mechanism of antagonist ligand binding to REV-ERBα
Multistep mechanism of substrate binding determines chaperone activity of Hsp70
The mechanism of action of the adrenomedullin-binding antibody adrecizumab
Biophysical characterization of the mechanism of large GTP-binding proteins
Mechanism, autonomy and biological explanation
Structural mechanism of SGLT1 inhibitors
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K‐Ras4b Inhibitors
Unmasking the biological function and regulatory mechanism of NOC2L: a novel inhibitor of histone acetyltransferase
Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation
Biological functions of proteases and inhibitors
Characterization of the bipartite binding mechanism of Yos9
Mechanism of Action of Halofenate, A Platelet Inhibitor
Mechanism of antagonist ligand binding to REV-ERBα
Multistep mechanism of substrate binding determines chaperone activity of Hsp70
The mechanism of action of the adrenomedullin-binding antibody adrecizumab
Biophysical characterization of the mechanism of large GTP-binding proteins
Mechanism, autonomy and biological explanation
Structural mechanism of SGLT1 inhibitors
Synthesis, Biological Evaluation, and Binding Mode of a New Class of Oncogenic K‐Ras4b Inhibitors
Unmasking the biological function and regulatory mechanism of NOC2L: a novel inhibitor of histone acetyltransferase
Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation
Biological functions of proteases and inhibitors
Characterization of the bipartite binding mechanism of Yos9
Mechanism of Action of Halofenate, A Platelet Inhibitor
Mechanism of antagonist ligand binding to REV-ERBα
Multistep mechanism of substrate binding determines chaperone activity of Hsp70
The mechanism of action of the adrenomedullin-binding antibody adrecizumab
Biophysical characterization of the mechanism of large GTP-binding proteins